Menu
GeneBe

SULF2

sulfatase 2, the group of Sulfatases

Basic information

Region (hg38): 20:47656196-47786616

Links

ENSG00000196562NCBI:55959OMIM:610013HGNC:20392Uniprot:Q8IWU5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SULF2 gene.

  • Inborn genetic diseases (51 variants)
  • not provided (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULF2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
2
clinvar
5
missense
49
clinvar
3
clinvar
1
clinvar
53
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 49 6 3

Variants in SULF2

This is a list of pathogenic ClinVar variants found in the SULF2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-47661793-C-T not specified Uncertain significance (Dec 13, 2021)2363081
20-47661845-C-T not specified Uncertain significance (Aug 12, 2021)2395225
20-47661855-G-T not specified Uncertain significance (Dec 15, 2022)2335130
20-47663080-T-C not specified Uncertain significance (Jul 29, 2022)2231927
20-47663093-C-T not specified Uncertain significance (Jul 20, 2021)2238729
20-47663149-T-C not specified Uncertain significance (Jun 26, 2023)2606492
20-47663162-T-G not specified Uncertain significance (Jan 03, 2024)2366945
20-47663191-G-T not specified Uncertain significance (Dec 19, 2022)2336552
20-47663456-T-A not specified Uncertain significance (May 03, 2023)2543056
20-47663466-C-T Likely benign (Jul 06, 2018)756056
20-47663467-G-A not specified Uncertain significance (Jul 26, 2022)2303297
20-47663474-G-T not specified Uncertain significance (Feb 23, 2023)2471234
20-47663617-C-T Likely benign (Jul 10, 2018)770670
20-47664166-C-T Benign (Jul 23, 2018)781567
20-47664171-T-A not specified Uncertain significance (Jun 24, 2022)2296809
20-47664182-T-C not specified Likely benign (May 05, 2023)2543978
20-47664187-T-C not specified Uncertain significance (Dec 01, 2022)2330648
20-47665200-T-C not specified Uncertain significance (Mar 11, 2022)2409615
20-47665250-C-T not specified Uncertain significance (Mar 14, 2023)2467999
20-47665859-C-T not specified Uncertain significance (Oct 05, 2021)3172017
20-47665939-T-A not specified Uncertain significance (Jul 09, 2021)2391670
20-47666256-T-C Benign (Jul 30, 2018)769999
20-47666285-C-T not specified Uncertain significance (Apr 13, 2022)2284161
20-47666286-G-A Likely benign (Jun 12, 2018)749579
20-47666297-C-T not specified Uncertain significance (Jul 12, 2023)2601116

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SULF2protein_codingprotein_codingENST00000359930 20130269
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01060.9891257240241257480.0000954
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.724425560.7950.00003685733
Missense in Polyphen169255.190.662252624
Synonymous0.2552252300.9790.00001661593
Loss of Function4.571346.70.2780.00000240533

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002160.000210
Ashkenazi Jewish0.00009930.0000992
East Asian0.0003330.000326
Finnish0.00004650.0000462
European (Non-Finnish)0.00004430.0000439
Middle Eastern0.0003330.000326
South Asian0.0002050.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity. It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin.;

Intolerance Scores

loftool
0.0167
rvis_EVS
-1.59
rvis_percentile_EVS
3.08

Haploinsufficiency Scores

pHI
0.147
hipred
Y
hipred_score
0.639
ghis
0.510

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.665

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sulf2
Phenotype
muscle phenotype; craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; respiratory system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
kidney development;chondrocyte development;glomerular filtration;response to wounding;positive regulation of vascular endothelial growth factor production;esophagus smooth muscle contraction;positive regulation of Wnt signaling pathway;heparan sulfate proteoglycan metabolic process;glomerular basement membrane development;glial cell-derived neurotrophic factor receptor signaling pathway;negative regulation of fibroblast growth factor receptor signaling pathway;embryonic skeletal system development;cartilage development;bone development;innervation;positive regulation of canonical Wnt signaling pathway;liver regeneration;regulation of hepatocyte proliferation
Cellular component
extracellular space;endoplasmic reticulum;Golgi stack;plasma membrane;cell surface
Molecular function
arylsulfatase activity;calcium ion binding;glycosaminoglycan binding;N-acetylglucosamine-6-sulfatase activity